These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9869447)

  • 1. Identical variant TSG101 transcripts in soft tissue sarcomas and various non-neoplastic tissues.
    Willeke F; Ridder R; Bork P; Klaes R; Mechtersheimer G; Schwarzbach M; Zimmer D; Kloor M; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Mol Carcinog; 1998 Dec; 23(4):195-200. PubMed ID: 9869447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours.
    Gayther SA; Barski P; Batley SJ; Li L; de Foy KA; Cohen SN; Ponder BA; Caldas C
    Oncogene; 1997 Oct; 15(17):2119-26. PubMed ID: 9366528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancer.
    Oh Y; Proctor ML; Fan YH; Su LK; Hong WK; Fong KM; Sekido YS; Gazdar AF; Minna JD; Mao L
    Oncogene; 1998 Sep; 17(9):1141-8. PubMed ID: 9764824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Truncated TSG101 transcripts in human leukemia and lymphoma cell lines.
    Hosokawa Y; Nagai E; Seto M
    J Cancer Res Clin Oncol; 2000 Feb; 126(2):79-84. PubMed ID: 10664246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of TSG101 transcript abnormalities in human cancers.
    Trink B; Pai SI; Spunt SL; Raman V; Cairns P; Jen J; Gabrielson E; Sukumar S; Sidransky D
    Oncogene; 1998 May; 16(21):2815-8. PubMed ID: 9652749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of tumor susceptibility gene TSG101 in human papillary thyroid carcinomas.
    Liu RT; Huang CC; You HL; Chou FF; Hu CC; Chao FP; Chen CM; Cheng JT
    Oncogene; 2002 Jul; 21(31):4830-7. PubMed ID: 12101421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 induction prevents accumulation of aberrant transcripts in cancer cells.
    Moyret-Lalle C; Duriez C; Van Kerckhove J; Gilbert C; Wang Q; Puisieux A
    Cancer Res; 2001 Jan; 61(2):486-8. PubMed ID: 11212237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic architecture and transcriptional activation of the mouse and human tumor susceptibility gene TSG101: common types of shorter transcripts are true alternative splice variants.
    Wagner KU; Dierisseau P; Rucker EB; Robinson GW; Hennighausen L
    Oncogene; 1998 Nov; 17(21):2761-70. PubMed ID: 9840940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of TSG101 in uterine cervix cancer.
    O'Boyle JD; Proctor ML; Fong KM; Lin WM; Miller DS; Muller CY
    Gynecol Oncol; 1999 Dec; 75(3):401-5. PubMed ID: 10600297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress-induced aberrant splicing of TSG101: association to high tumor grade and p53 status in breast cancers.
    Turpin E; Dalle B; de Roquancourt A; Plassa LF; Marty M; Janin A; Beuzard Y; de Thé H
    Oncogene; 1999 Dec; 18(54):7834-7. PubMed ID: 10618725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a new isoform of the tumor susceptibility TSG101 protein lacking a leucine zipper domain in Burkitt lymphoma cell lines.
    Ferrer M; López-Borges S; Lazo PA
    Oncogene; 1999 Apr; 18(13):2253-9. PubMed ID: 10327071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of TSG101 tumour susceptibility gene transcripts in cervical and endometrial cancers.
    Chang JG; Su TH; Wei HJ; Wang JC; Chen YJ; Chang CP; Jeng CJ
    Br J Cancer; 1999 Feb; 79(3-4):445-50. PubMed ID: 10027311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant splicing of the TSG101 tumor suppressor gene in human breast and ovarian cancers.
    Carney ME; Maxwell GL; Lancaster JM; Gumbs C; Marks J; Berchuck A; Futreal PA
    J Soc Gynecol Investig; 1998; 5(5):281-5. PubMed ID: 9773405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
    Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
    Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of cellular TSG101 protein in multiple human breast cancer cell lines.
    Zhong Q; Chen CF; Chen Y; Chen PL; Lee WH
    Cancer Res; 1997 Oct; 57(19):4225-8. PubMed ID: 9331081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent loss of expression or aberrant alternative splicing of P2XM, a p53-inducible gene, in soft-tissue tumours.
    Nawa G; Miyoshi Y; Yoshikawa H; Ochi T; Nakamura Y
    Br J Cancer; 1999 Jun; 80(8):1185-9. PubMed ID: 10376970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of truncated FHIT transcripts in cervical cancers and in normal human cells.
    Matthews CP; Shera K; Kiviat N; McDougall JK
    Oncogene; 2001 Aug; 20(34):4665-75. PubMed ID: 11498789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [TSG101 and breast cancer: a correctly named tumor-suppressor gene?].
    Bénard J; Ahomadégbé JC
    Bull Cancer; 1997 Dec; 84(12):1141-2. PubMed ID: 9587367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UQCRH gene encoding mitochondrial Hinge protein is interrupted by a translocation in a soft-tissue sarcoma and epigenetically inactivated in some cancer cell lines.
    Modena P; Testi MA; Facchinetti F; Mezzanzanica D; Radice MT; Pilotti S; Sozzi G
    Oncogene; 2003 Jul; 22(29):4586-93. PubMed ID: 12881716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.